- Home
- FluxMPS™ Dulbecco's Modified Eagle Medium(DMEM), Low Glucose, 25mM HEPES w/o Phenol Red: 1X Liquid
FluxMPS™ Dulbecco's Modified Eagle Medium(DMEM), Low Glucose, 25mM HEPES w/o Phenol Red: 1X Liquid
FluxMPS™ DCP-DMEMLH-R1X is a Microfluidics Suitable, quadruple-stage ultra-filtered (0.1 µm ×2 + 0.04 µm ×2) DMEM Low Glucose formulation with 25 mM HEPES and no phenol red, engineered for microphysiological systems (MPS), organ-on-a-chip (OoC), and microfluidic tissue models. The 44 mM sodium bicarbonate base is supplemented with HEPES for extended pH stability during atmospheric handling, while phenol red removal reduces optical background from that component for imaging and biosensor applications.
- Quadruple-stage filtration train: 0.1 µm Prefiltration I → 0.04 µm Final filtration I → 0.1 µm Prefiltration II → 0.04 µm Final filtration II, reaching a 0.04 µm final pore size
- Endotoxin release specification: < 0.05 EU/mL (LAL, USP <85>), tested per manufacturing batch
- Low Glucose formulation (1 g/L D-Glucose) with L-Glutamine (584 mg/L) and Sodium Pyruvate (110 mg/L) for defined carbon-source control
- 25 mM HEPES (pKa 7.3 at 37°C) supplements the 44 mM sodium bicarbonate buffer system for extended pH stability during atmospheric handling and open-well procedures
- Phenol red–free formulation reduces optical background from that component for confocal microscopy and biosensor applications
- Manufactured under an ISO 13485:2016 quality management system, with per-lot Certificate of Analysis
- Custom pH, salts, glucose concentration, and nutrient adjustments available on request
- Formulation[+] L-Glutamine, [+] Sodium Bicarbonate, [+] HEPES, [+] Calcium, [+] Magnesium, [+] Glucose (Low), [+] Sodium Pyruvate | [-] Phenol Red
- AppearanceColorless to pale yellow, clear solution
- pH (USP <791>)7.4
- Osmolality (USP <785>)310–350 mOsm/kg H2O
- Endotoxin (USP <85>)< 0.05 EU/mL
- Filtration0.1 µm ×2 + 0.04 µm ×2
- CO2 Requirement10% CO2 recommended (bicarbonate-buffered); HEPES extends atmospheric stability
- Storage2–8°C, away from light
- Shelf Life12 months from date of manufacture, unopened
- ShippingCold pack
Engineered where standard media fails
Conventional 0.22 µm–filtered media passes mycoplasma-sized particles, subvisible particulates, and endotoxin fragments that clog microfluidic channels and corrupt sensor signals. FluxMPS™ mitigates these failure modes with a four-stage 0.1/0.04 µm filtration train.
Microchannel-safe purity
0.04 µm final filtration; USP <788> Method 1 (light obscuration) particulate compliance supports safe perfusion across chip geometries.
Total metabolic control
Defined Low Glucose, L-Glutamine, and sodium pyruvate levels give researchers precise control over carbon-source and nitrogen inputs for metabolic studies.
Ultrapure-grade water
Ultrapure Type 1 water (18.2 MΩ·cm) feed-water with tight trace-metal and organic-carbon control supports sensitive electrophysiology and biosensor work.
Low background for imaging
Quadruple-stage filtration provides an ultra-low particulate baseline for confocal microscopy and biosensor applications; phenol red is excluded from this formulation to remove that specific optical interference.
Rich, stable nutrient profile
33 verified ingredients per lot; micro-batch production with full raw-material traceability.
Customization on demand
pH, glucose, salts, HEPES, and nutrients adjustable per your protocol. Contact support@diagnocine.com.
Quadruple-stage filtration system
Four serial filtration stages — two paired prefilter + final-filter cycles — reach a final 0.04 µm polish, providing sub-mycoplasma-scale particulate control for microfluidic channels below 100 µm.
-
1
0.1 µm Prefiltration I
Removes large aggregates, cell debris, and protein aggregates; protects the first 0.04 µm cartridge.
-
2
0.04 µm Final filtration I
Retains sub-micron particulates, including mycoplasma-scale material (0.2–0.3 µm), that pass a standard 0.22 µm filter.
-
3
0.1 µm Prefiltration II
Second dedicated prefilter, protecting the second 0.04 µm final-filter cartridge.
-
4
0.04 µm Final filtration II — Polish
Ultimate polishing filter; aseptic fill & finish.
Performance vs. conventional media
FluxMPS™ DCP-DMEMLH-R1X runs a paired 0.1 µm / 0.04 µm filtration train twice in series, reaching a 0.04 µm final pore size versus the 0.22 µm single-pass filtration typical of conventional media.
© Diagnocine® — DCP-DMEMLH-R1X
Designed for next-generation cell models
FluxMPS™ DCP-DMEMLH-R1X supports platforms from single-channel microfluidic chips to multi-organ body-on-a-chip systems. The supplemental 25 mM HEPES buffer extends pH stability for open-well microfluidic handling.
Automated Bioreactors & Robotics
An optional 0.01 µm (10 nm) ultra-filtered MPS Grade variant is available on request for automated bioreactor perfusion and robotic liquid handlers — see the Grade note above.
- Total Particulate Exclusion: 10 nm filtration removes nanoparticulate aggregates
- Valve & Sensor Protection: Reduces micro-fouling of solenoid valves and inline optical sensors
- Extended Perfusion Stability: Consistent nutrient delivery over weeks-long culture
Inquiry Required: Contact support@diagnocine.com for the 0.01 µm MPS Grade variant.
Micro Physiological System (MPS) & Chip
Ultra-clean 0.04 µm–filtered media reduces microchannel clogging risk in multi-organ chip architectures.
CHO & Mammalian Cell Culture
Suited to CHO, cancer cell lines, and primary cells requiring a low-glucose, HEPES-buffered background.
iPSC-Derived Models
Ultra-low endotoxin (< 0.05 EU/mL release specification) and multi-stage mycoplasma-retentive filtration support sensitive iPSC protocols.
Endothelial & Primary Cells
Low-particulate, endotoxin-controlled media supports HUVEC monolayer integrity and TEER monitoring.
Metabolic Flux Analysis
Defined Low Glucose, L-Glutamine, and sodium pyruvate levels support 13C isotope tracing and NMR-based metabolomics. Not compatible with Agilent Seahorse XF assays, which require bicarbonate-free, phenol red-free medium.
Microscopy & Optical Sensing
Ultra-low particulate background supports confocal imaging and biosensor platforms; phenol red is excluded to remove that specific interference source.
Analytical release specifications
Every lot released against the full specification matrix. CoA: support@diagnocine.com.
| Parameter | Specification |
|---|---|
| Formulation | [+] L-Glutamine, [+] Sodium Bicarbonate, [+] HEPES, [+] Calcium, [+] Magnesium, [+] Glucose (Low), [+] Sodium Pyruvate | [-] Phenol Red |
| Appearance | Colorless to pale yellow, clear solution |
| pH USP <791> | 7.4 |
| Osmolality USP <785> | 310–350 mOsm/kg H2O |
| Glucose | 1000 mg/L (Low Glucose) |
| L-Glutamine | 584 mg/L |
| Sodium Pyruvate | 110 mg/L |
| HEPES | 5958 mg/L (25 mM), pKa 7.3 at 37°C |
| Phenol Red | None / not added |
| Parameter | Specification |
|---|---|
| Endotoxin USP <85> BET | < 0.05 EU/mL (per manufacturing batch) |
| Sterility USP <71> | No growth / 14 days |
| Mycoplasma | 0.1/0.04 µm mycoplasma-retentive filtration (not tested per lot) |
| Particulate ≥10 µm USP <788> Method 1 | NMT 25/mL |
| Particulate ≥25 µm USP <788> Method 1 | NMT 3/mL |
| Water purity | Type 1, 18.2 MΩ·cm |
| Manufacturing std. | ISO 13485:2016 |
| Fill environment | ISO Class 5 (Class 100) |
| Parameter | Specification |
|---|---|
| Storage temperature | 2–8°C, away from light |
| Freeze-thaw | Do not freeze |
| Shelf life | 12 months from date of manufacture, unopened |
| Shipping condition | Cold pack |
| CO2 requirement | 10% CO2 recommended (44 mM sodium bicarbonate buffering system); supplemental 25 mM HEPES extends pH stability for atmospheric handling but does not eliminate the need for CO2-supplemented incubation |
| Parameter | Specification |
|---|---|
| Raw material grade | Reagent / cell culture grade |
| Traceability | Full lot traceability per ISO 13485 |
| Manufacturing QMS ISO | ISO 13485:2016 certified |
| UNSPSC | 41116155 — Molecular biology and cell culture growth media (UNv260801) |
| Regulatory alignment | 21 CFR Part 820 (QMSR) aligned |
| Production method | Micro-batch, per-lot QC release |
| Intended use | Research Use Only (RUO) |
Full composition (mg/L)
Total: 33 components across 4 categories, verified per lot with CAS numbers for raw-material traceability.
| Component | CAS Number | mg/L |
|---|---|---|
| INORGANIC SALTS | ||
| Calcium chloride dihydrate | 10035-04-8 | 265.000 |
| Ferric nitrate nonahydrate | 7782-61-8 | 0.100 |
| Magnesium sulfate anhydrous | 7487-88-9 | 97.720 |
| Potassium chloride | 7447-40-7 | 400.000 |
| Sodium bicarbonate | 144-55-8 | 3700.000 |
| Sodium chloride | 7647-14-5 | 6400.000 |
| Sodium dihydrogen phosphate anhydrous | 7558-80-7 | 109.000 |
| Component | CAS Number | mg/L |
|---|---|---|
| AMINO ACIDS | ||
| Glycine | 56-40-6 | 30.000 |
| L-Arginine hydrochloride | 1119-34-2 | 84.000 |
| L-Cystine dihydrochloride | 30925-07-6 | 62.570 |
| L-Glutamine | 56-85-9 | 584.000 |
| L-Histidine hydrochloride monohydrate | 5934-29-2 | 42.000 |
| L-Isoleucine | 73-32-5 | 105.000 |
| L-Leucine | 61-90-5 | 105.000 |
| L-Lysine hydrochloride | 657-27-2 | 146.000 |
| L-Methionine | 63-68-3 | 30.000 |
| L-Phenylalanine | 63-91-2 | 66.000 |
| L-Serine | 56-45-1 | 42.000 |
| L-Threonine | 72-19-5 | 95.000 |
| L-Tryptophan | 73-22-3 | 16.000 |
| L-Tyrosine Disodium Salt dihydrate | 69847-15-0 | 103.790 |
| L-Valine | 72-18-4 | 94.000 |
| Component | CAS Number | mg/L |
|---|---|---|
| VITAMINS | ||
| Choline chloride | 67-48-1 | 4.000 |
| D-Ca-Pantothenate | 137-08-6 | 4.000 |
| Folic acid | 59-30-3 | 4.000 |
| Nicotinamide | 98-92-0 | 4.000 |
| Pyridoxal hydrochloride | 65-22-5 | 4.000 |
| Riboflavin | 83-88-5 | 0.400 |
| Thiamine hydrochloride | 67-03-8 | 4.000 |
| OTHERS | ||
| D-Glucose | 50-99-7 | 1000.000 |
| Sodium pyruvate | 113-24-6 | 110.000 |
| HEPES | 7365-45-9 | 5958.000 |
| i-Inositol | 87-89-8 | 7.200 |
Manufacturing & compliance
Every FluxMPS™ product is manufactured and released under a multi-layer quality system spanning raw materials, in-process controls, and final-product testing.
ISO 13485:2016 Quality Management
Manufactured under ISO 13485:2016-certified facilities. Final QA at Diagnocine R&D Center, Totowa, NJ, USA.
Ultrapure Type 1 Water
18.2 MΩ·cm feed water with tight trace-metal and organic-carbon control.
ISO Class 5 Fill & Finish
Aseptic fill in validated ISO Class 5 (Class 100) laminar-flow workstations.
Micro-Batch Precision
Small-batch production, full per-lot traceability, Certificate of Analysis for every lot.
Endotoxin — USP <85> BET
LAL assay, assay sensitivity 0.005 EU/mL; release specification < 0.05 EU/mL per batch.
Particulate — USP <788> Method 1
Light obscuration: NMT 25/mL (≥10 µm), NMT 3/mL (≥25 µm).
Osmolality — USP <785>
Freezing-point osmometry. Target: 310–350 mOsm/kg H2O.
Documentation & CoA
Full CoA with raw-material traceability available for every lot on request.
- Endotoxin — LAL assay, USP <85> Bacterial Endotoxins Test; assay sensitivity 0.005 EU/mL; release specification < 0.05 EU/mL
- pH, osmolality, conductivity, appearance and clarity
- Sterility
How DCP-DMEMLH-R1X compares
FluxMPS™ DCP-DMEMLH-R1X vs. conventional 0.22 µm–filtered DMEM Low Glucose + HEPES formulations.
| Parameter | DCP-DMEMLH-R1X (FluxMPS™) | Conventional DMEM Low Glucose + HEPES (0.22 µm filtered) |
Standard Alt. (0.22 µm filtered) |
|---|---|---|---|
| Grade | Microfluidics Suitable | Standard grade | Standard grade |
| HEPES-buffered, phenol red–free formulation | check_circle Yes | cancel No | cancel No |
| Final filtration pore size | 0.04 µm | 0.22 µm | 0.22 µm |
| Number of filtration stages | 4 (Quadruple) | 1 | 1 |
| Mycoplasma-retentive filtration | check_circle Yes | cancel No | cancel No |
| Endotoxin (release specification) | FluxMPS™ — < 0.05 EU/mL | Corning classical liquid media — < 0.25 EU/mL Sigma-Aldrich DMEM complete medium — ≤ 2 EU/mL Gibco classical DMEM — Not specified (recorded per lot) |
|
| USP <788> particulate tested | check_circle Yes | cancel No | cancel No |
| Water quality | Type 1, 18.2 MΩ·cm | Purified water | Purified water |
| Manufacturing QMS | ISO 13485:2016 | ISO 9001 or none | ISO 9001 or none |
| Microfluidic channel compatible | check_circle Yes (Microfluidics Suitable) | cancel Risk of clogging | cancel Risk of clogging |
| Custom formulation | check_circle Available | cancel Fixed | cancel Fixed |
Comparison figures from published supplier specifications, accessed 2026-09-02. Suppliers that publish no numeric endotoxin specification are shown as "Not specified".
Frequently asked questions
Common questions about FluxMPS™ DCP-DMEMLH-R1X.
Supporting literature
Key peer-reviewed publications supporting Microfluidics Suitable, ultra-filtered media in organ-on-a-chip and microfluidic research.
- Huh D, et al. Reconstituting organ-level lung functions on a chip. Science. 2010;328:1662–1668. doi:10.1126/science.1188302
- Bhatia SN, Ingber DE. Microfluidic organs-on-chips. Nat Biotechnol. 2014;32:760–772. doi:10.1038/nbt.2989
- Ham RG. Clonal growth of mammalian cells in a chemically defined, synthetic medium. Proc Natl Acad Sci USA. 1965;53:288–293. doi:10.1073/pnas.53.2.288
- Novak R, et al. Robotic fluidic coupling and interrogation of multiple vascularized organ chips. Nat Biomed Eng. 2020;4:407–420. doi:10.1038/s41551-019-0497-x
- Jang KJ, et al. Human kidney proximal tubule-on-a-chip for drug transport and nephrotoxicity assessment. Integr Biol. 2013;5:1119–1129. doi:10.1039/c3ib40049b
- Schimek K, et al. Integrating biological vasculature into a multi-organ-chip microsystem. Lab Chip. 2013;13:3588–3598. doi:10.1039/c3lc50217a
- Luni C, et al. High-efficiency cellular reprogramming with microfluidics. Nat Methods. 2016;13:446–452. doi:10.1038/nmeth.3832
- Sung JH, et al. Microfabricated mammalian organ systems and their integration into models of whole animals and humans. Lab Chip. 2013;13:1201–1212. doi:10.1039/c3lc41017j






